Kit Check Announces the Latest Bluesight for Controlled Substances Feature, Investigation Portfolios
Summary
Investigating suspected diversion is a challenging task that requires immediate, consistent response and action in order to identify a potential diverter and maintain the safety of the hospital’s patients and the community at large. “It’s another tool for hospitals to use in the fight against the opioid crisis, and to keep their patients and staff safe.” BCS was created to provide visibility and insight into the large amounts of data that come from the hospitals’ ADCs and EMR. However, such events do happen, as is evidenced in part by the opioid epidemic facing the U.S. To date, Bluesight for Controlled Substances has documented over 1 million cases, of which 90 to 95% are auto-closed by the system. Our solutions blend powerful machine learning and advanced tracking technology to streamline medication inventory, workflow, and auditing processes and help hospital pharmacies cut costs, reduce risk, and get more done. To date, our more than 500 U.S. and Canadian hospital partners have tracked over 50 million medications using the Kit Check and BluesightTM for Controlled Substances software.